Apr 11, 2017 - Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Mar 09, 2017 - Sucampo Pharmaceuticals, Inc. (SCMP) reported adjusted earnings of 68 cents per share in the fourth quarter of 2016, beating the Zacks Consensus Estimate of 49 cents by 38.8%.
Jul 28, 2016 - Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Thursday
Jul 27, 2016 - Dr. Reddy's (RDY) reported first-quarter fiscal 2017 earnings per American Depositary Share of 11 cents, down 79.6% from the year-ago quarter.
Jul 27, 2016 - Dr. Reddy’s Laboratories Limited (NYSE:RDY) Q2 2016 Earnings Conference Call July 26, 2016 09:00 ET Executives Kedar Upadhye - Investor Relations Saumen Chakraborty - Chief Financial Officer Abhijit M
Jul 14, 2016 - Teva (TEVA) provided its preliminary outlook for 2016-2019 and expects the Actavis Generics acquisition to go through anytime soon.
Jul 13, 2016 - The short term earnings outlook for these stocks have been building momentum recently, so don't miss out!
Feb 09, 2016 - Dr. Reddy's Laboratories Limited (NYSE:RDY) Q3 2016 Earnings Conference Call February 9, 2016 8:00 AM ET Executives Kedar Upadhye – Investor Relations Saumen Chakraborty – Chief Financial Officer Abhi
Oct 29, 2015 - Dr. Reddy's Laboratories Limited (NYSE:RDY) Q2 2016 Earnings Conference Call October 29, 2015, 09:00 AM EDT Executives Kedar Upadhye - Head of Global Generics Finance & Investor Relations Saumen C
Sep 21, 2015 - BioMarin (BMRN) announced that it has entered into a settlement agreement with Dr. Reddy's (RDY) to resolve the patent litigation related to Kuvan.